Allarity Therapeutics Inc (ALLR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALLR Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Allarity Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent16.98
Cash & Short-term Investments16.00
Income Taxes Receivable, Current NO1.31
Other Current Assets10.06
Prepaid Expense, Current AS3.38
Total Current Assets31.73
Equipment/Property/Plant Net0.39
Restricted Cash Current10.00
Total Assets32.12
Liabilities
Accounts Payable, Current AC4.11
Accrued Liabilities, Current AC1.97
Derivative Liability, Current DE0.13
Short-term Debt DE120.86
Other Liabilities, Current1.42
Taxes Payable, Current, Total0.08
Total Current Liabilities28.58
Total Long-term Debt0.00
Total Liabilities28.58
Stockholders' Equity
Treasury Stock Common Value-3.45
Common Stock Value0.00
Additional Paid In Capital Common Stock144.68
Retained Earnings / Accumulated Deficit-136.35
Accumulated Other Comprehensive Income-1.35
Other Equity-1.35
Common Stockholder's Equity3.54
Total Stockholder's Equity3.54
Liabilities & Stockholder's Equity32.12
4 historic quarters locked

Sign in to unlock the full Allarity Therapeutics Inc balance sheet history.

About Allarity Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-027830

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.